ACCESSION: MSBNK-SMB_Measured-HSA015P0111022
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 17
COMMENT: RAW_SPEC {'EL19_pos_1924': {'bp': 167403.0, 'sum': 676398.0}, 'EL23_pos_1901': {'bp': 99623.0, 'sum': 568373.0}, 'EL04_pos_1907': {'bp': 94916.0, 'sum': 497367.0}, 'EL02_pos_1919': {'bp': 164905.0, 'sum': 667733.0}, 'EL16_pos_2051': {'bp': 98473.0, 'sum': 574993.0}, 'EL22_pos_1924': {'bp': 166818.0, 'sum': 678302.0}, 'EL17_pos_2055': {'bp': 105218.0, 'sum': 578667.0}, 'EL24_pos_1906': {'bp': 84117.0, 'sum': 484113.0}, 'EL11_pos_1913': {'bp': 126864.0, 'sum': 510139.0}, 'EL12_pos_1919': {'bp': 138189.0, 'sum': 590218.0}, 'EL14_pos_1918': {'bp': 134008.0, 'sum': 542930.0}, 'EL01_pos_1911': {'bp': 119958.0, 'sum': 485617.0}, 'EL01_pos_2074': {'bp': 88536.0, 'sum': 481580.0}, 'EL08_pos_2069': {'bp': 87267.0, 'sum': 504020.0}, 'EL04_pos_2069': {'bp': 85773.0, 'sum': 489596.0}, 'EL01_pos_1769': {'bp': 81638.0, 'sum': 418132.0}, 'EL24_pos_1786': {'bp': 79713.0, 'sum': 444969.0}}
COMMENT: RETENTION_TIME_STDEV 0.153
COMMENT: PRECURSOR_M/Z_RAW 111.092112
COMMENT: PRECURSOR_M/Z_STDEV 0.000048
COMMENT: PRECURSOR_IN_MS1 mz 111.091672; int 27.641; delta(ppm) 0.671143
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.018; C6H10N2; [M+H]+; delta(ppm) -0.018168
COMMENT: PROPOSED_MF MS-FINDER 2.748; C6H10N2; [M+H]+; delta(ppm) -0.024896
COMMENT: PROPOSED_MF SIRIUS5_Sirius 30.023; C6H10N2; [M+H]+; delta(ppm) -0.024896
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) -0.024896
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.191; C6H10N2; [M+H]+; delta(ppm) -0.024896
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) -0.024896
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.574; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; CCCC1=CC=NN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.250; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; N1=NC2CCC1CC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.150; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; CCC1=NC=C(C)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; N[C]1[CH][CH][C]([CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; N[C]1[C]([CH][CH][CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.420; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.420; VTNUQSAAFBRENH-UHFFFAOYSA-N; [M+H]+; 1,2-dimethyl-1??-pyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.351; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.351; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.143; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.143; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.143; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.981; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.962; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.962; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.904; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.483; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.034; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.537; YAVXLTMRALFZIS-UHFFFAOYSA-N; [M+H]+; piperidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; SFEKRFLQOGMHSZ-UHFFFAOYSA-N; [M+H]+; 2-[1-(aminomethyl)cyclopropyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.327; UEBWHAAQVVWZAU-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.326; MRGFCRUGPMFUHD-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.322; YBTQATWVNNDUDN-UHFFFAOYSA-N; [M+H]+; 2-(3-aminocyclobutyl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.276; HERJCJRIDHRCKG-UHFFFAOYSA-N; [M+H]+; 2-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.276; PKTNSCWXNMMDQK-UHFFFAOYSA-N; [M+H]+; 3-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; FSDNTQSJGHSJBG-UHFFFAOYSA-N; [M+H]+; piperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.187; ZGNXATVKGIJQGC-UHFFFAOYSA-N; [M+H]+; piperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.186; KFPMRYNOEZCHDP-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; ZKKCALAGXBADEJ-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; ZICRALLMHKILDG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; FVPYQTSLDMVWBM-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; LZECJKUQMLXNBD-UHFFFAOYSA-N; [M+H]+; 1-amino-2,2-dimethylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; WVMBISZHWMJNNM-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.151; HUVAAOZUPLEYBH-UHFFFAOYSA-N; [M+H]+; 3,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.150; YAXKXMVDJJMGRY-UHFFFAOYSA-N; [M+H]+; 4-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; JTAPOORUPPEREW-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; VGFGZZVMDIZSTI-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopropylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; FUOZJYASZOSONT-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; IAZZNTYMXXEHHT-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; HNOQAFMOBRWDKQ-UHFFFAOYSA-N; [M+H]+; 1,3,5-trimethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; KYCDNQPIQHCAFW-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; ZBJSHMBQYSDTGK-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; RFBQAWJJJXBCSN-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.914; HINMGNHBDCADKG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; ZAXITHHHFYZUGN-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; MKBBSFGKFMQPPC-UHFFFAOYSA-N; [M+H]+; 2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; NPRYXVXVLCYBNS-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; KMBJEVSXNIUPIH-UHFFFAOYSA-N; [M+H]+; 3-(aziridin-1-yl)butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; NALRGBZDHLOOTD-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; GGCBARJYVAPZJQ-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; ZAOLDHBNVDOBDU-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.722; NVPICXQHSYQKGM-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; IPIORGCOGQZEHO-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; PTBPTNCGZUOCBK-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.434; IYVYLVCVXXCYRI-UHFFFAOYSA-N; [M+H]+; 1-propylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.396; HPDIRFBJYSOVKW-UHFFFAOYSA-N; [M+H]+; 2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.379; ZOORJGVSPXCZCJ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.378; ANMVTDVBEDVFRB-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.368; VDSAXHBDVIUOGV-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.360; NYYVCPHBKQYINK-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.360; BDMFEFZOOOYCKN-UHFFFAOYSA-N; [M+H]+; 1-propylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.338; OZHWHTICSNFGBZ-UHFFFAOYSA-N; [M+H]+; 3-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.334; UMMIQMAIGBATCS-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -69.425; NVPICXQHSYQKGM; [M+H]+; 1-Cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.997; PKTNSCWXNMMDQK; [M+H]+; 3-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.483; NPRYXVXVLCYBNS; [M+H]+; Pyrrolidinoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.562; JOHCCHGNXMXHPU; [M+H]+; 2,3-Diazabicyclo(2.2.2)oct-2-ene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.691; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.636; FSDNTQSJGHSJBG; [M+H]+; ACMC-20aipl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.064; ZGNXATVKGIJQGC; [M+H]+; 3-cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.558; KFPMRYNOEZCHDP; [M+H]+; Ambcb4035549
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.688; OZHWHTICSNFGBZ; [M+H]+; ACMC-20ankz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.194; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.605; KMBJEVSXNIUPIH; [M+H]+; 3-(1-Aziridinyl)butyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.195; NJIDBKRVRJXCLL; [M+H]+; 1-methyl-2H-pyridin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.700; WLWHLUQQCLCFNE; [M+H]+; 1-ethenyl-3-methyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.073; ZOORJGVSPXCZCJ; [M+H]+; 1-(Dimethylamino)pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.416; ZICRALLMHKILDG; [M+H]+; zlchem 589
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.875; VDSAXHBDVIUOGV; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.721; ANMVTDVBEDVFRB; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.865; IPIORGCOGQZEHO; [M+H]+; 1-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.334; HPDIRFBJYSOVKW; [M+H]+; pyrrolylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.435; HUVAAOZUPLEYBH; [M+H]+; 3,4,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.239; NYYVCPHBKQYINK; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.736; QBNRQCHCKIIYGV; [M+H]+; 3-Propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.254; HNOQAFMOBRWDKQ; [M+H]+; Pyrazole, 1,3,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.739; GGCBARJYVAPZJQ; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.479; NJMWOUFKYKNWDW; [M+H]+; Meetimcl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.968; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimdazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.807; ULKLGIFJWFIQFF; [M+H]+; Imidazole C-2 deriv. 2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.959; IYVYLVCVXXCYRI; [M+H]+; propylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.183; PTBPTNCGZUOCBK; [M+H]+; 2,4,5-Trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.442; HINMGNHBDCADKG; [M+H]+; 5-propan-2-yl-1H-imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.749; BDMFEFZOOOYCKN; [M+H]+; propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.193; MKBBSFGKFMQPPC; [M+H]+; zlchem 316
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.302; NVPICXQHSYQKGM; [M+H]+; 1-Cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.323; JOHCCHGNXMXHPU; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.597; MBAJKEJMOVVLRP; [M+H]+; 2,5-Dihydro-3,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.935; ZOKOWWYVKANQNJ; [M+H]+; 4-Methyl-1,2,3,6-tetrahydropyridine-2-imine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.969; UEBWHAAQVVWZAU; [M+H]+; 1-(Aminomethyl)cyclobutanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -125.170; NVPICXQHSYQKGM; [M+H]+; 1-Piperidinecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -132.708; HERJCJRIDHRCKG; [M+H]+; 2-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.463; KFPMRYNOEZCHDP; [M+H]+; (1-Cyanocyclopentyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.353; OZHWHTICSNFGBZ; [M+H]+; 3-(Cyclopropylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.744; PKTNSCWXNMMDQK; [M+H]+; 3-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -148.238; SRTDZDDEFUNXJL; [M+H]+; 4-Methyl-1,2,5,6-tetrahydropyridine-2-imine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.185; JOHCCHGNXMXHPU; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H11N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.131
MS$FOCUSED_ION: PRECURSOR_M/Z 111.091672
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-6900000000-c250d105995e92a0cb17
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388771 28.9729 53.039575 1.3575 6.12 0.7143 14 f{C4H5}/5.67ppm,p-C2H6N2
  55.0180791 47.2192 55.018787 0.8543 9.11 0.7413 12 ?
  55.0545163 191.7380 55.055224 0.6539 32.63 0.8358 17 f{C4H7}/5.26ppm,p-C2H4N2
  56.0496978 25.4907 56.050410 1.1775 9.38 -0.1703 13 f{C3H6N1}/3.96ppm,p-C3H5N1
  65.0387455 54.0452 65.039484 0.9840 15.04 0.5853 16 f{C5H5}/2.60ppm,p-C1H6N2
  67.0543997 272.7928 67.055141 0.4325 48.44 0.7034 17 f{C5H7}/2.58ppm,p-C1H4N2
  68.0496620 77.6608 68.050404 1.2050 25.38 0.3353 16 f{C4H6N1}/2.74ppm,p-C2H5N1
  68.9972451 46.8889 68.997988 1.2609 18.53 0.6294 16 ?
  69.0336376 141.7396 69.034381 0.7098 31.91 0.5907 17 ?
  69.0699851 76.2349 69.070728 0.7529 14.44 0.6147 16 f{C5H9}/1.57ppm,p-C1H2N2
  70.0652767 166.3170 70.066020 0.7279 73.82 -0.1103 17 f{C4H8N1}/2.16ppm,p-C2H3N1
  70.9418974 71.0382 70.942641 0.6907 14.18 0.6593 17 ?
  79.0542998 33.2478 79.055032 0.9234 8.27 0.5286 15 f{C6H7}/0.93ppm,p-H4N2
  80.9451597 31.5704 80.945887 1.2972 10.70 0.1642 17 ?
  81.0699095 70.5753 81.070636 0.8511 17.27 0.2868 17 f{C6H9}/0.40ppm,p-H2N2
  83.0491781 58.4883 83.049898 1.0235 11.36 0.7157 17 ?
  83.0855800 71.5420 83.086299 0.8786 12.24 0.7500 16 f{C6H11}/0.64ppm,p-N2
  84.0444752 23.0239 84.045191 1.4397 7.17 0.1608 12 ?
  84.0807945 78.3758 84.081510 1.0347 77.01 0.2500 15 f{C5H10N1}/0.22ppm,p-C1H1N1
  86.9927406 65.3544 86.993443 0.9196 15.09 0.5956 17 ?
  91.0541672 30.0886 91.054847 1.1641 7.92 0.6484 13 ?
  93.0698962 32.2957 93.070563 1.3753 9.34 0.1516 14 ?
  95.0490994 35.6769 95.049752 1.0310 7.35 0.6308 14 ?
  100.0243877 54.3909 100.025000 1.1897 15.61 0.3897 17 ?
  105.0033286 64.6675 105.003893 1.0571 15.12 0.5294 16 ?
  109.0647244 26.7914 109.065253 1.1828 5.70 0.5594 12 ?
  109.0763454 24.4891 109.076874 1.8061 9.73 -0.1049 12 f{C6H9N2}/2.94ppm,p-H2
  109.0841554 70.6643 109.084684 1.5126 50.02 -0.4056 12 ?
  109.1011679 64.0595 109.101697 0.9807 13.28 0.6373 17 ?
  110.0601023 207.2892 110.060624 0.6178 115.27 -0.4387 17 ?
  111.0441166 95.0025 111.044631 1.2427 12.18 0.7819 17 ?
  111.0553624 57.2269 111.055877 1.1076 11.30 0.7000 16 ?
  111.0917110 999.0000 111.092225 0.3781 0.00 1.0000 17 f{C6H11N2}/0.33ppm,p
  112.0392958 44.3509 112.039803 0.9818 15.30 -0.0760 17 ?
  112.0503917 38.0961 112.050899 1.0799 14.44 -0.2500 15 ?
  112.0757561 227.9227 112.076263 0.7584 97.90 0.5711 17 ?
  112.0950395 65.4051 112.095546 1.5076 13.02 0.6294 16 ?
  112.1121226 70.1687 112.112629 0.9633 18.46 0.3748 12 ?
  113.0233293 56.0151 113.023829 0.8936 15.56 0.1446 17 ?
  113.0346199 41.5982 113.035119 1.2032 17.09 0.0179 15 ?
  113.0597532 135.1826 113.060252 1.0260 25.95 0.6667 17 ?
  113.1073229 24.0701 113.107822 1.1317 4.28 0.6993 12 ?
  116.9662917 38.0395 116.966758 1.2140 9.12 0.5659 13 ?
  130.9819380 40.0159 130.982261 1.2903 12.36 0.0500 16 ?
PK$NUM_PEAK: 44
PK$PEAK: m/z int. rel.int.
  53.038877 28.97 28
  55.018079 47.22 47
  55.054516 191.74 191
  56.049698 25.49 25
  65.038746 54.05 54
  67.054400 272.79 272
  68.049662 77.66 77
  68.997245 46.89 46
  69.033638 141.74 141
  69.069985 76.23 76
  70.065277 166.32 166
  70.941897 71.04 71
  79.054300 33.25 33
  80.945160 31.57 31
  81.069910 70.58 70
  83.049178 58.49 58
  83.085580 71.54 71
  84.044475 23.02 23
  84.080795 78.38 78
  86.992741 65.35 65
  91.054167 30.09 30
  93.069896 32.30 32
  95.049099 35.68 35
  100.024388 54.39 54
  105.003329 64.67 64
  109.064724 26.79 26
  109.076345 24.49 24
  109.084155 70.66 70
  109.101168 64.06 64
  110.060102 207.29 207
  111.044117 95.00 95
  111.055362 57.23 57
  111.091711 999.00 999
  112.039296 44.35 44
  112.050392 38.10 38
  112.075756 227.92 227
  112.095040 65.41 65
  112.112123 70.17 70
  113.023329 56.02 56
  113.034620 41.60 41
  113.059753 135.18 135
  113.107323 24.07 24
  116.966292 38.04 38
  130.981938 40.02 40
//
